Carlson Capital’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-775,000
Closed -$65.9M 221
2020
Q3
$65.9M Buy
+775,000
New +$39.2M 1.93% 9

Carlson Capital's IMMU Position: Q4 2020 in Review

Carlson Capital sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 775,000 shares — an estimated $65.9M sold.

Carlson Capital first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $65.9M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Carlson Capital reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Carlson Capital sold 775,000 Immunomedics Inc shares in Q4 2020, an estimated $65.9M.
  • Carlson Capital first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
  • Carlson Capital's Immunomedics Inc position peaked at $65.9M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Carlson Capital's 13F filing for Q4 2020, filed 12 Feb 2021.